Evidence & policy library
Every pathway is linked to the organizations responsible for the decision.
17 source records
Methodology
Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.
Matching documents: 30
Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
APAC
🇮🇩 IndonesiaOfficialNotice and service-reference context; linked service-standard annex not reviewed in this cycle.2025-08-06Latest observed: 2025-08-06
🇮🇩 IndonesiaOfficialClinical, economic and health-system assessment for policy recommendations.Undated institutional pageLatest observed: Undated institutional page
🇮🇩 IndonesiaOfficialCurrent listing notice and prescribing-reference purpose, not product-specific payment.Decision 2025-12-31; application 2026-04-01Latest observed: 2025-12-31
🇮🇩 IndonesiaOfficialPublic library/API linkage to the actual decision and proposal files; library dates are not all legal effective dates.Library includes documents through 2026-04-07Latest observed: 2026-04-07
🇮🇩 IndonesiaOfficialPublic library/API linkage to the actual decision and proposal files; library dates are not all legal effective dates.Library includes documents through 2026-04-07Latest observed: 2026-04-07
🇮🇩 IndonesiaOfficialArticles 1–2 and roles of doctors, coders and BPJS verifiers; selected clauses, not all coding cases.2021-08-30Latest observed: 2021-08-30
🇮🇩 Indonesia
OfficialArticles 1–2 and roles of doctors, coders and BPJS verifiers; selected clauses, not all coding cases.2021-08-30Latest observed: 2021-08-30
🇮🇩 IndonesiaOfficialV6 implementation and displayed-price negotiation boundary; historical transition dates are not current deadlines.2024-12-27Latest observed: 2024-12-27
🇮🇩 IndonesiaOfficialSelected governance, selection, revision and limited non-formulary clauses; read with PMK 5/2026 and the current Fornas decision.Guide 2020; library posting 2021-09-03Latest observed: 2021-09-03
🇮🇩 IndonesiaOfficialSelected governance, selection, revision and limited non-formulary clauses; read with PMK 5/2026 and the current Fornas decision.Guide 2020; library posting 2021-09-03Latest observed: 2021-09-03
🇮🇩 IndonesiaOfficialArticles 1–13 distinguish development and clinical-trial approval from marketing authorisation; not a universal launch clock.2025-08-20Latest observed: 2025-08-20
🇮🇩 Indonesia
OfficialArticles 1–13 distinguish development and clinical-trial approval from marketing authorisation; not a universal launch clock.2025-08-20Latest observed: 2025-08-20
🇮🇩 IndonesiaOfficialSelected topic selection, recommendation, objections, economic/BIA and conditional adaptive-HTA sections; no product recommendation is inferred.Book 2022; website posting 2025-02-10Latest observed: 2025-02-10
🇮🇩 IndonesiaOfficialSelected topic selection, recommendation, objections, economic/BIA and conditional adaptive-HTA sections; no product recommendation is inferred.Book 2022; website posting 2025-02-10Latest observed: 2025-02-10
🇮🇩 IndonesiaOfficialSelected Articles 9, 37, 40–44, 50–52, 58, 62, 106–112 and 122–126; transition and surviving rules retained, no unverified maximum-price rate.2026-05-04Latest observed: 2026-05-04
🇮🇩 Indonesia
OfficialSelected Articles 9, 37, 40–44, 50–52, 58, 62, 106–112 and 122–126; transition and surviving rules retained, no unverified maximum-price rate.2026-05-04Latest observed: 2026-05-04
🇮🇩 IndonesiaOfficialSelected definitions, amended Article 37, transition and labelling provisions; route clocks are conditional.2025-08-12Latest observed: 2025-08-12
🇮🇩 Indonesia
OfficialSelected definitions, amended Article 37, transition and labelling provisions; route clocks are conditional.2025-08-12Latest observed: 2025-08-12
🇮🇩 IndonesiaOfficialSelected authorisation, variation, renewal and post-market principles; the original is not a consolidated 2026 text and its old clocks are not used.2017; amended through BPOM 23/2025Latest observed: 2025-08-12
🇮🇩 Indonesia
OfficialSelected authorisation, variation, renewal and post-market principles; the original is not a consolidated 2026 text and its old clocks are not used.2017; amended through BPOM 23/2025Latest observed: 2025-08-12
🇮🇩 IndonesiaOfficialOperative clauses and introductory item/restriction/facility notation, physical pages 1 and 3–8; not all 224 pages or product entries.Adopted 2025-12-31; formulary applies 2026-04-01Latest observed: 2025-12-31
🇮🇩 Indonesia
OfficialOperative clauses and introductory item/restriction/facility notation, physical pages 1 and 3–8; not all 224 pages or product entries.Adopted 2025-12-31; formulary applies 2026-04-01Latest observed: 2025-12-31
🇮🇩 IndonesiaOfficialEleven-page instructions: eligible proposers, allowed revisions, HTA routing/programme exception, supporting documents and submission/completeness steps; no open-window inference.Library posting 2026-04-07; 2026 addendumLatest observed: 2026-04-07
🇮🇩 IndonesiaOfficialEleven-page instructions: eligible proposers, allowed revisions, HTA routing/programme exception, supporting documents and submission/completeness steps; no open-window inference.Library posting 2026-04-07; 2026 addendumLatest observed: 2026-04-07
🇮🇩 Indonesia
OfficialDecision clauses on specified categories and consolidation-storefront exclusion, physical pages 1–6; individual amount tables not audited.2024-10-23Latest observed: 2024-10-23
🇮🇩 IndonesiaOfficialCurrent-cycle evidence of topic selection and interim objections; dated examples are not final product coverage or an open submission window.Notices 2026-08-19, 2026-09-03 and 2026-09-09Latest observed: 2026-09-09
🇮🇩 IndonesiaOfficialCurrent-cycle evidence of topic selection and interim objections; dated examples are not final product coverage or an open submission window.Notices 2026-08-19, 2026-09-03 and 2026-09-09Latest observed: 2026-09-09
🇮🇩 IndonesiaOfficialCurrent-cycle evidence of topic selection and interim objections; dated examples are not final product coverage or an open submission window.Notices 2026-08-19, 2026-09-03 and 2026-09-09Latest observed: 2026-09-09
🇮🇩 IndonesiaOfficialSelected Articles 1–3, 11, 25–27 and 33–44 on payment categories; 721-page annex not exhaustively reviewed and no current product rate is certified.2023-01-09Latest observed: 2023-01-09
🇮🇩 Indonesia
OfficialSelected Articles 1–3, 11, 25–27 and 33–44 on payment categories; 721-page annex not exhaustively reviewed and no current product rate is certified.2023-01-09Latest observed: 2023-01-09
For education only — not regulatory, pricing or legal advice.